Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

81.

Choosing Benefits while Balancing Risks.

N. Engl. J. Med.
Greene MF, Ecker JL.
| Dec 31, 2015
82.

Selexipag for the Treatment of Pulmonary Arterial Hypertension.

N. Engl. J. Med.
Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV, Amuchastegui M.
| Dec 24, 2015
83.

Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.

N. Engl. J. Med.
Shaw AT, Friboulet L, Leshchiner I, Gainor JF, Bergqvist S, Brooun A, Burke BJ, Deng YL, Liu W, Dardaei L, Frias RL, Schultz KR, Logan J, James LP, Smeal T, Timofeevski S, Katayama R, Iafrate AJ, Le L, McTigue M, Getz G, Johnson TW, Engelman JA.
| Jan 7, 2016
84.

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.

N. Engl. J. Med.
Byrd JC, Harrington B, O'Brien S, Jones JA, Schuh A, Devereux S, Chaves J, Wierda WG, Awan FT, Brown JR, Hillmen P, Stephens DM, Ghia P, Barrientos JC, Pagel JM, Woyach J, Johnson D, Huang J, Wang X, Kaptein A, Lannutti BJ, Covey T, Fardis M, McGreivy J, Hamdy A, Rothbaum W, Izumi R, Diacovo TG, Johnson AJ, Furman RR.
| Jan 28, 2016
85.

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.

N. Engl. J. Med.
Roberts AW, Davids MS, Pagel JM, Kahl BS, Puvvada SD, Gerecitano JF, Kipps TJ, Anderson MA, Brown JR, Gressick L, Wong S, Dunbar M, Zhu M, Desai MB, Cerri E, Heitner Enschede S, Humerickhouse RA, Wierda WG, Seymour JF.
| Jan 28, 2016
86.

Estimating the Long-Term Treatment Benefits of Sacubitril-Valsartan.

N. Engl. J. Med.
Claggett B, Packer M, McMurray JJ, Swedberg K, Rouleau J, Zile MR, Jhund P, Lefkowitz M, Shi V, Solomon SD.
| Dec 3, 2015
87.

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.

N. Engl. J. Med.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Aizenberg D.
| Dec 3, 2015
88.

Tenuous Tether.

N. Engl. J. Med.
Edelman ER, Weber BN.
| Dec 3, 2015
89.

Hypoplastic Metatarsals--Beyond Cosmesis.

N. Engl. J. Med.
Sharma A, Phillips AJ, Jüppner H.
| Nov 26, 2015
90.

IMAGES IN CLINICAL MEDICINE. Tension Pneumoperitoneum.

N. Engl. J. Med.
Kaafarani HM.
| Nov 19, 2015
91.

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.

N. Engl. J. Med.
Foster GR, Afdhal N, Roberts SK, Bräu N, Gane EJ, Pianko S, Lawitz E, Thompson A, Shiffman ML, Cooper C, Towner WJ, Conway B, Ruane P, Bourlière M, Asselah T, Berg T, Zeuzem S, Rosenberg W, Agarwal K, Stedman CA, Mo H, Dvory-Sobol H, Han L, Wang J, McNally J, Osinusi A, Brainard DM, McHutchison JG, Mazzotta F, Tran TT, Gordon SC, Patel K, Reau N, Mangia A, Sulkowski M, Afdhal N.
| Dec 31, 2015
92.

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.

N. Engl. J. Med.
Curry MP, O'Leary JG, Bzowej N, Muir AJ, Korenblat KM, Fenkel JM, Reddy KR, Lawitz E, Flamm SL, Schiano T, Teperman L, Fontana R, Schiff E, Fried M, Doehle B, An D, McNally J, Osinusi A, Brainard DM, McHutchison JG, Brown RS, Charlton M, Al-Assi TM.
| Dec 31, 2015
93.

Antidote for Factor Xa Anticoagulants.

N. Engl. J. Med.
Connors JM.
| Dec 17, 2015
94.

Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation.

N. Engl. J. Med.
Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung JW, Voisine P, Dagenais F, Gillinov AM, Thourani V, Argenziano M, Gammie JS, Mack M, Demers P, Atluri P, Rose EA, O'Sullivan K, Williams DL, Bagiella E, Michler RE, Weisel RD, Miller MA, Geller NL, Taddei-Peters WC, Smith PK, Moquete E, Overbey JR, Kron IL, O'Gara PT, Acker MA, Miller MA.
| Jan 28, 2016
95.

Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.

N. Engl. J. Med.
Redfield MM, Anstrom KJ, Levine JA, Koepp GA, Borlaug BA, Chen HH, LeWinter MM, Joseph SM, Shah SJ, Semigran MJ, Felker GM, Cole RT, Reeves GR, Tedford RJ, Tang WH, McNulty SE, Velazquez EJ, Shah MR, Braunwald E.
| Dec 10, 2015
96.

Soluble Urokinase Receptor and Chronic Kidney Disease.

N. Engl. J. Med.
Hayek SS, Sever S, Ko YA, Trachtman H, Awad M, Wadhwani S, Altintas MM, Wei C, Hotton AL, French AL, Sperling LS, Lerakis S, Quyyumi AA, Reiser J.
| Nov 12, 2015
97.

Parachutes and Preferences--A Trial of Knee Replacement.

N. Engl. J. Med.
Katz JN.
| Oct 22, 2015
99.

Improving Value in Health Care--Against the Annual Physical.

N. Engl. J. Med.
Mehrotra A, Prochazka A.
| Oct 15, 2015
100.

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

N. Engl. J. Med.
Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW, Stone GW.
| Nov 12, 2015